Fengyan Jin
- Molecular Biology
- Cancer Research top 10%
- Hematology top 5%
- Oncology top 10%
- Immunology top 10%
- Co-authors
- Dirk M. HermannThorsten R. DoeppnerYun DaiUlf BrockmeierAnil ZechariahEric MetzenNina HagemannFriedrich Otterbach
- Topics
- Multiple Myeloma Research and Treatments (22 papers)Protein Degradation and Inhibitors (14 papers)Angiogenesis and VEGF in Cancer (8 papers)
- Cited by
- HematologyNeurologyCancer Research
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Fengyan Jin
61 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 660
- Cancer Research 298
- Hematology 295
- Oncology 271
- Immunology 265
Countries citing papers authored by Fengyan Jin
This map shows the geographic impact of Fengyan Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengyan Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengyan Jin more than expected).
Fields of papers citing papers by Fengyan Jin
This network shows the impact of papers produced by Fengyan Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengyan Jin. The network helps show where Fengyan Jin may publish in the future.
Co-authorship network of co-authors of Fengyan Jin
This figure shows the co-authorship network connecting the top 25 collaborators of Fengyan Jin. A scholar is included among the top collaborators of Fengyan Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengyan Jin. Fengyan Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 8 | |
| 8 | 7 | |
| 9 | 27 | |
| 10 | 37 | |
| 11 | 8 | |
| 12 | 40 | |
| 13 | 17 | |
| 14 | 37 | |
| 15 | 7 | |
| 16 | 13 | |
| 17 | 23 | |
| 18 | 107 | |
| 19 | 16 | |
| 20 | 59 |
About Fengyan Jin
Fengyan Jin is a scholar working on Hematology, Neurology and Cancer Research, having authored 69 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (22 papers), Protein Degradation and Inhibitors (14 papers) and Angiogenesis and VEGF in Cancer (8 papers). The work is most often cited by research in Hematology (295 citations), Neurology (199 citations) and Cancer Research (298 citations). Fengyan Jin has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Dirk M. Hermann, Thorsten R. Doeppner, Yun Dai, Ulf Brockmeier, Anil Zechariah, Eric Metzen, Nina Hagemann, Friedrich Otterbach, Ayman ElAli and Iris Helfrich. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.